Ashton Thomas Private Wealth’s Halozyme HALO Stock Holding History

Ashton Thomas Private Wealth’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$985K	Buy	15,234 +5,648	+59%	+$398K	0.02%	543
2025 Q4	$645K	Buy	9,586 +343	+4%	+$23.1K	0.02%	602
2025 Q3	$678K	Buy	9,243 +2,379	+35%	+$158K	0.02%	576
2025 Q2	$357K	Buy	6,864 +2,694	+65%	+$153K	0.01%	642
2025 Q1	$266K	Buy	+4,170	New	+$242K	0.01%	687
2024 Q4	–	Sell	-3,791	Closed	-$217K	–	787
2024 Q3	$217K	Buy	3,791 +71	+2%	+$4.07K	0.01%	574
2024 Q2	$195K	Buy	+3,720	New	+$163K	0.01%	571
2022 Q3	–	Sell	-27,986	Closed	-$1.23M	–	461
2022 Q2	$1.23M	Sell	27,986 -608	-2%	-$26.3K	0.13%	187
2022 Q1	$1.14M	Buy	28,594 +5,429	+23%	+$193K	0.1%	229
2021 Q4	$931K	Buy	+23,165	New	+$865K	0.09%	250

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ashton Thomas Private Wealth's HALO Position: Q1 2026 in Review

Ashton Thomas Private Wealth increased its Halozyme (HALO) stake by 59% in Q1 2026, buying an estimated $398K and bringing the position to 15,234 shares worth $985K. The position accounts for 0.02% of the portfolio, ranked #543.

Ashton Thomas Private Wealth first reported a position in HALO in Q4 2021 and has held it in 10 quarters since. The position peaked at $1.23M in Q2 2022. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

Ashton Thomas Private Wealth held 15,234 shares of Halozyme worth $985K as of Q1 2026.
Ashton Thomas Private Wealth bought 5,648 Halozyme shares in Q1 2026, an estimated $398K.
Halozyme made up 0.02% of Ashton Thomas Private Wealth's portfolio in Q1 2026, its #543 holding.
Ashton Thomas Private Wealth first reported a position in Halozyme in Q4 2021 and has held it in 10 quarters since.
Ashton Thomas Private Wealth's Halozyme position peaked at $1.23M in Q2 2022.
634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Ashton Thomas Private Wealth's 13F filing for Q1 2026, filed 11 May 2026.